(Q41105687)

26 September 2017

Tamoxifen inhibits prolactin signal transduction in ER - NOG-8 mammary epithelial cells (English)

1 reference

26 September 2017

1 reference

R Das

1

1 reference

PubMed ID

9177456

26 September 2017

B K Vonderhaar

series ordinal

2

1 reference

PubMed ID

9177456

26 September 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

26 September 2017

1 reference

26 September 2017

116

1 reference

26 September 2017

1

1 reference

26 September 2017

41-46

1 reference

Prolactin receptors in human breast cancer

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2904750-2

7 January 2021

Characterization of a monoclonal antibody against human prolactin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2904750-2

7 January 2021

Tamoxifen for breast cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2904750-2

7 January 2021

Characteristics of a membrane-associated antilactogen binding site for tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2904750-2

7 January 2021

Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2904750-2

7 January 2021

Tamoxifen Inhibition of Prolactin Action in the Mouse Mammary Gland

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2904750-2

7 January 2021

Epithelial cell cultures from normal glandular tissue of mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2904750-2

7 January 2021

Prolactin-induced protein kinase C activity in a mouse mammary cell line (NOG-8)

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2904750-2

7 January 2021

Prolactin as a mitogen in mammary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2904750-2

7 January 2021

Tamoxifen inhibits growth of oestrogen receptor-negative A549 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2904750-2

7 January 2021

Molecular mechanisms of antiestrogen action in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2904750-2

7 January 2021

Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2904750-2

7 January 2021

Is tamoxifen also an anti-lactogen?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2904750-2

7 January 2021

Inhibition of protein kinase C mediated signal transduction by tamoxifen. Importance for antitumour activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2904750-2

7 January 2021

Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2904750-2

7 January 2021

Mitogen-activated protein kinase activation resulting from selective oncogene expression in NIH 3T3 and rat 1a cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2904750-2

7 January 2021

Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2904750-2

7 January 2021

10.1016/S0304-3835(97)04750-2

Identifiers

DOI

1 reference

26 September 2017

1 reference

PubMed ID

9177456